BiotechTube
Home/Humanetics Corp./Matthew L. Nathan, M.D.
ML

Matthew L. Nathan, M.D.

Leadership

Humanetics Corp.

Therapeutic Areas

OncologyPulmonologyBiodefense

Humanetics Corp. Pipeline

DrugIndicationPhase
BIO 300Non-Small Cell Lung Cancer (with radiotherapy)Phase 2

Leadership Team at Humanetics Corp.

RJ
Ronald J. Zenk, MBA
Leadership (likely CEO/President)
CG
Colin G. Chinn, M.D., MHS, FACP
Chief Medical Officer
TE
Timothy E. Morris
Chief Operating Officer
BR
Barbara R. Holcomb, RN, BSN, MSN
Board Member
View full Humanetics Corp. profile